Prmt22157-08.anp.07090

The following is a list of the most commonly prescribed drugs. It represents an abbreviatedversion of the drug list (formulary) that is at the core of your prescription-drug benefit plan.
The list is not all-inclusive and does not guarantee coverage. In addition to using this list,you are encouraged to ask your doctor to prescribe generic drugs whenever appropriate.
PLEASE NOTE: The symbol * next to a drug signifies that it is subject to nonformulary status
2008 Express Scripts
when a generic is available throughout the year. Not all the drugs listed are covered by all
prescription-drug benefit programs; check your benefit materials for the specific drugs

National Preferred Formulary
covered and the copayments for your prescription-drug benefit program. For specific
questions about your coverage, please call the phone number printed on your ID card.

A
B
K
N
D
L
G
C
E
O
H
M
I
P
F
J
THIS DOCUMENT LIST IS EFFECTIVE JAN. 1, 2008 THROUGH DEC. 31, 2008. THIS LIST IS SUBJECT TO CHANGE.
The symbol [G] next to a drug name signifies that a generic is available for at least one or more strengths of the brand-name medication. Most generics are available at the lowest copayment.
You can get more information and updates to this document at our web site at www.express-scripts.com.
2008 Express Scripts, Inc.
PRMT22157-08 (09/01/07)
All Rights Reserved
Examples of Nonformulary Medications With Selected Formulary Alternatives
The following is a list of some nonformulary brand-name medications with examples of selected alternatives that are on the formulary.
Column 1 lists examples of nonformulary medications.
Column 2 lists some alternatives that can be prescribed.
Nonformulary
Formulary Alternative
Nonformulary
Formulary Alternative
M-tabs), Seroquel/XR, Zyprexa (non-Zydis) brimonidine tartrate, Alphagan P, Cosopt*, U
Q
ciprofloxacin/er, ofloxacin, Avelox, Levaquin brimonidine tartrate, Alphagan P, Cosopt*, R
V
paroxetine (immediate release), citalopram, amlodipine, felodipine er, nifedipine er, fluoxetine (daily), citalopram, paroxetine, S
W
amlodipine, felodipine er, nifedipine er, X
ciprofloxacin/er, ofloxacin, Avelox, Levaquin Y
Z
M-tabs), Seroquel/XR, Zyprexa (non-Zydis) T
The symbol [G] next to a drug name indicates that a generic is available for at least one or more strengths of the brand-name medication.
The symbol [INJ] next to a drug name indicates that the drug is available in injectable form only.
The symbol [SNRI] stands for Serotonin-Norepinephrine Reuptake Inhibitor.
For the member: Generic medications contain the same active ingredients as their corresponding brand-name medications, although they may
look different in color or shape. They have been FDA-approved under strict standards.
For the physician: Please prescribe preferred products and allow generic substitutions when medically appropriate. Thank you.
Brand-name drugs are listed in CAPITAL letters.
Generic drugs are listed in lower case letters.
THIS DOCUMENT LIST IS EFFECTIVE JAN. 1, 2008 THROUGH DEC. 31, 2008. THIS LIST IS SUBJECT TO CHANGE.
The symbol [G] next to a drug name signifies that a generic is available for at least one or more strengths of the brand-name medication. Most generics are available at the lowest copayment.
You can get more information and updates to this document at our web site at www.express-scripts.com.
2008 Express Scripts, Inc.
PRMT22157-08 (09/01/07)
All Rights Reserved

Source: http://www.fcebenefits.com/cms/pdf/ESI2008Formulary.pdf

helsingborgslasarett.se

T h e n e w e ng l a n d j o u r na l o f m e dic i n e Interactive at www.nejm.org Management of Type 2 Diabetes This interactive feature addresses the diagnosis or management of a clinical case. A case vignette is fol owed by specific clinical options, none of which can be considered either correct or incorrect. In short essays, experts in the field then argue for each of the o

Microsoft word - mainz - parameterkatalog_austria_v1.

Register schweres Asthma - Erfassungsbogen Register schweres Asthma 1. Definition schweres Asthma Diagnose schweres Asthma Besteht bei Ihrem Patienten ein schweres Asthma nach beigefügter Definition? 2. Basisdaten Datum der aktuellen Untersuchung (dd.mm.yyyy): ____________ Geburtsdatum des Patienten (mm.yyyy): ___________ Wohnort des Patienten: ________________

Copyright © 2010-2014 Online pdf catalog